Synthesis of 6-(3,5-dichlorobenzyl) derivatives as isosteric analogues of the HIV drug 6-(3,5-dimethylbenzyl)-1-(ethoxymethyl)-5-isopropyluracil (GCA-186).
Esben R Sørensen, Nasser R El-Brollosy, Per T Jørgensen, Erik B Pedersen, Claus Nielsen
Index: Arch. Pharm. (Weinheim) 338(7) , 299-304, (2005)
Full Text: HTML
Abstract
The HIV-1 inhibitors described in this paper is closely related to 6-(3,5-dimethylbenzyl)-1-(ethoxy methyl)-5-isopropyluracil (GCA-186) an anti-HIV-1 drug that is highly active against both wild type and mutated HIV-1 strains. The two methyl groups on the 6-benzyl moiety have been shown to improve the binding stability of the drug to the NNRTI-binding site in reverse transcriptase of drug mediated mutant HIV-1 viruses. The methyl groups are replaced with isosteric chloro-atoms to avoid metabolism due to the two methyl groups. However, the isosteric chloro derivatives show tenfold less activity against HIV-1 than their corresponding methyl derivatives. The synthesis and the antiviral activities of the corresponding 1-(allyloxy- and indanyloxy)methyl-6-(3,5-dichlorobenzyl)-5-ethyluracil derivatives are also reported.
Related Compounds
Related Articles:
Iridium catalysed alkylation of tert-butyl cyanoacetate with alcohols under solvent free conditions. Grigg R, et al.
[Tetrahedron 65(4) , 849-54, (2009)]